Medochemie and Theramir: Strategic Biotechnology Partnership
Cypriot pharmaceutical company Medochemie and biotechnology company Theramir announced a strategic investment and cooperation agreement. The goal is to develop next-generation therapies based on extracellular vesicles and mRNA, as well as to promote biotechnology and advanced pharmaceutical production in Cyprus and Southeast Europe.